Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Heart Rhythm. 2014 May 13;11(6):925–932. doi: 10.1016/j.hrthm.2014.03.006

Figure 1.

Figure 1

Derivation of study population and persistence of AAD therapy. Patients were stratified by baseline AAD use: amiodarone, other AAD, or no AAD. AAD=antiarrhythmic drug; ITT=intention-to-treat; ROCKET AF= Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation.